The US Food and Drug Administration (FDA) on Thursday expanded authorization of the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds.
from NDTV News - Latest https://ift.tt/3rRLYFo
Subscribe to:
Post Comments (Atom)
-
By BY THE NEW YORK TIMES from NYT U.S. https://ift.tt/2JDppgp
-
By BY ERIC GRODE from NYT Theater https://ift.tt/32KJU7H
No comments:
Post a Comment